Study participants at risk for Alzheimer's want to know their pote... ( ANN ARBOR Mich.If you had a family h...)

Study participants at risk for Alzheimer's want to know their potential fate

Date:12/12/2011

ANN ARBOR, Mich.If you had a family history of developing Alzheimer's disease, would you take a genetic test that would give you more information about your chances?

"Definitely," said Gloria VanAlstine, 60, and Joyce Smith, 79. The two women took a controversial genetic test of a gene called Apolipoprotein E. APOE is a susceptibility gene where certain variants have been found to significantly increase a person's risk of developing Alzheimer's disease. Both women have a family history of Alzheimer's, which increases risk.

The genetic test was conducted as part of the Risk Evaluation and Education for Alzheimer's disease Study (REVEAL), a series of clinical trials taking place at U-M School of Public Health, with other sites including Harvard University, Howard University, and the University of Pennsylvania.

APOE testing is controversial in the medical community because the variant is neither necessary nor sufficient to cause Alzheimer's disease. This limitation, along a with a general lack of treatment options for Alzheimer's, has raised concerns that the genetic information could burden rather than benefit patients. There have been numerous consensus statements and articles against using APOE genotyping for predicting Alzheimer's risk.

However, most of the study participants who took the test, including VanAlstine and Smith, wanted to learn about their APOE test results and were not overtly distressed by them, said Scott Roberts, associate professor in U-M SPH, and co-principal investigator of REVEAL, along with Robert Green at Harvard University School of Medicine.

The National Society of Genetic Counselors and American College of Medical Genetics recently developed practice guidelines for genetic counseling and testing for Alzheimer's disease. Roberts is one of the authors.

The guidelines provide clinicians with a framework for assessing their patients' genetic risk for Alzheimer's disease, identifyin
'/>"/>

Contact: Laura Bailey
baileylm@umich.edu
734-764-1552
University of Michigan
Source:Eurekalert

0

GOOD

Page: 1 2
Related medicine news :

1. Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study
2. American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time
3. TV drama can be more persuasive than news program, study finds
4. Study carried out into biological risks of eating reptiles
5. Neuroimaging study may pave way for effective Alzheimers treatments
6. Study finds racial gaps continue in heart disease awareness
7. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
8. First blinded study of venous insufficiency prevalence in MS shows promising results
9. Soothing infants with food focus of childhood obesity study
10. People with anxiety disorder less able to regulate response to negative emotions, study shows
11. American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women

Post Your Comments:

(Date:5/21/2013)... May 22, 2013 Feed additives have ... production industry value chain. Most of the feed additives ... injectable, pellets, liquids, and powders. There are variety of ... and concentrations depending upon the type of animal and ... vitamins that provide essential nutrition to the animal in ...

(Date:5/21/2013)... (PRWEB) May 21, 2013 Medical Ministry ... the prestigious 2013 Top-Rated Award by GreatNonprofits , the ... are excited to be named a Top-Rated 2013 Nonprofit,” says ... the dedication of our over 3000 Volunteers and Staff serving ... significant as it came from those that have seen our ...

(Date:5/21/2013)... on a large scale is the cornerstone of ... better outcomes, better value and better experience of ... patient-centered medical home model offers a viable solution ... of Health and Human Services, Agency for Healthcare ... more about the processes and determinants of successful ...

(Date:5/21/2013)... 21, 2013 Mecklenburg EMS Agency (Medic) ... hold a free Community Wellness Fair to educate the public ... will be held on Wednesday, May 22, 2013 from 4:00 ... (8100 Old Mallard Creek Road, Charlotte, NC 29262). ... and the Mecklenburg County Department of Social Services ...

(Date:5/21/2013)... May 2013, Paris, France: The Orsiro stent, which ... a biodegradable polymer, demonstrated non-inferiority to the Xience ... of in-stent late lumen loss at nine months ... at EuroPCR 2013 today. , The BIOFLOW-II substudy ... (OCT) to quantitatively assess neointimal hyperplasia and stent ...

Breaking Medicine News(10 mins):Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 2 Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 3 Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 4 Health News:Medical Ministry International Recognized as a 2013 Top-rated Nonprofit By GreatNonprofits.org 2 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5 Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6 Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2 Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2

[0] Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com [0] Medical Ministry International Recognized as a 2013 Top-rated Nonprofit By GreatNonprofits.org [0] AHRQ-funded journal supplement offers lessons on primary care practice transformation [0] Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives [0] Biodegradable stent proves non-inferior to drug-eluting stent

... 12 The Female Health Company (NYSE Alternext: ... (FDA) Obstetrics and Gynecology Devices Advisory Committee has unanimously voted ... is approvable with a single condition. , ... the product is approvable with the condition that the FC2 ...

... HOUSTON, Dec. 12 Access MediQuip, LLC, ... medical implantable device management,solutions to the healthcare ... industry,s first national contract for device benefit ... with WellPoint, Inc. to deliver,implantable device management ...

... and only approved peginterferon in combination with ribavirin for ... medical need , , ... SGP ) today announced that the U.S. Food ... PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) combination therapy ...

... director for the Pew Campaign on Human Health and ... U.S. Food and Drug Administration,s decision to reverse its ... animal agriculture: , , ... the increase in antibiotic-resistant infections - a fact long ...

... Hospitals Case Medical Center in conjunction with Sodexo Health Care ... Nosh 24/6 unit, the original certified kosher hot food vending ... machine in the state of Ohio, offering patients and their ... , , University Hospitals prides ...

... Life Insurance,Company (John Hancock) is reinforcing its commitment ... training requirements through an,affiliation with the ClearCert Clearinghouse. ... in the year and effective January 1, 2009,will ... , Since ...

Cached Medicine News:Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 2 Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 3 Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 4 Health News:FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable 5 Health News:Access MediQuip and WellPoint Finalize First National Contract for Implantable Medical Devices 2 Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 2 Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 3 Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 4 Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 5 Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 6 Health News:Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C 7 Health News:Statement From The Pew Charitable Trusts on the U.S. Food and Drug Administration's Reversal on Antibiotics Safeguards in Animal Farming 2 Health News:University Hospitals Case Medical Center Installs First Hot Kosher Vending Machine 2 Health News:University Hospitals Case Medical Center Installs First Hot Kosher Vending Machine 3 Health News:John Hancock Expands LTC Training Effort with ClearCert High Usage By Producers and Streamlines Process for Insurers 2 Health News:John Hancock Expands LTC Training Effort with ClearCert High Usage By Producers and Streamlines Process for Insurers 3

FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable Access MediQuip and WellPoint Finalize First National Contract for Implantable Medical Devices Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C Statement From The Pew Charitable Trusts on the U.S. Food and Drug Administration's Reversal on Antibiotics Safeguards in Animal Farming University Hospitals Case Medical Center Installs First Hot Kosher Vending Machine John Hancock Expands LTC Training Effort with ClearCert High Usage By Producers and Streamlines Process for Insurers

(Date:5/21/2013)... 21, 2013 Lakeland Industries, Inc. (NASDAQ: ... industrial protective clothing for industry, municipalities, healthcare and ... levels, today announced that the Company accepted a ... Credit Facility subject to certain terms and conditions ... However, no assurances can be given that this ...

(Date:5/21/2013)... May 21, 2013 Regulus Therapeutics Inc . ... discovery and development of innovative medicines targeting microRNAs, today ... Ph.D., Chief Operating Officer and Executive Vice President, Finance, ... 38th Annual Healthcare Conference on Wednesday, May 29, 2013 ... at the Westin Boston Waterfront Hotel. The ...

(Date:5/21/2013)... , May 21, 2013 Tom Daulton, CEO of Mammotome, ... of the Year by the Cincinnati ... was nominated by another local top executive who is also ... brand from Ethicon Endo-Surgery in March of 2010. Daulton will ... Awards program, presented by Huntington Bank, on May 22. ...

[0] Lakeland Industries, Inc. Reports Fiscal 2013 Fourth Quarter and Full Year Financial Results [0] Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference [0] Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year

... - VASTox plc (AIM: VOX), a leading,UK biotechnology ... of £400,000 by the Welsh Development Agency,(”WDA”) under ... 12 months, will support the research and development,work ... the unique skills and expertise of its scientists,based ...

... 2007 /PRNewswire-USNewswire/ -- The,following statement may be attributed ... Medical Research (CAMR): , "In the face of ... the stroke of his veto pen deliberately to ... well as endanger,the future health and well being ...

Cached Medicine Technology:Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility 2 Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility 3 President Bush Ignores America's Plea for Support of Stem Cell,Research 2

Vastox Awarded £400,000 Grant to Support R&D at,Carbohydrate Chemistry Facility President Bush Ignores America's Plea for Support of Stem Cell,Research

... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...

... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...

Medicine Products:

Dapsone, Serum or Plasma Dalmane D-lysergic Acid Diethylamide, Urine D, 1-25 Dihydroxy, Vitamin